Analysis of gene expression in whole tissues using real-time RT-PCR, DNA microarrays and RNA sequencing provides insight into the state of cells in tissues under normal and pathological conditions.

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher ...